Comparison of annual eGFR decline among primary kidney diseases in patients with CKD G3b-5: results from a REACH-J CKD cohort study.

Junichi HoshinoRyoya TsunodaKei NagaiHirayasu KaiChie SaitoYukiko ItoKoichi AsahiMasahide KondoKunitoshi IsekiChiho IsekiHirokazu OkadaNaoki KashiharaIchiei NaritaTakashi WadaChristian CombeRonald L PisoniBruce M RobinsonKunihiro Yamagata

Published in: Clinical and experimental nephrology (2021)

Our study revealed the disease-specific annual eGFR declines by CKD stages and the level of proteinuria. Comparing to the other kidney diseases, the declines in PKD patients were getting faster from early stages of CKD. These results suggest the importance of CKD managements in PKD patients from the early stages.

Keyphrases

chronic kidney disease
end stage renal disease
small cell lung cancer
ejection fraction
peritoneal dialysis
prognostic factors
epidermal growth factor receptor
patient reported outcomes
patient reported
polycystic kidney disease